Their discoveries uncovered the significant contributions of circRNA_104948 in the progression of glioma, highlighting that the circRNA_104948/miR-29b-3p/MTSS1/DNMT3B pathway holds promise as a potential therapeutic target for individuals diagnosed with glioma [51]. Here, DNMT3B is linked to central nervous system cancer.